Keyphrases
Glucose Metabolism
100%
Orexin System
100%
Suvorexant
100%
Db Mouse
100%
Type 2 Diabetic
100%
Type 2 Diabetes Mellitus (T2DM)
33%
Sleep Time
33%
Wakefulness
16%
Metabolism
16%
Liver
16%
Diabetic Mice
16%
Expression Level
16%
Peroxisome Proliferator-activated Receptor
16%
Insulin Sensitivity
16%
Inflammation
16%
Adipose Tissue
16%
Metabolic Disorders
16%
Lipid Metabolism
16%
MRNA Level
16%
Food Intake
16%
REM Sleep
16%
Phosphoenolpyruvate Carboxylase
16%
Diabetic
16%
Glucose Tolerance
16%
Impaired Glucose Tolerance
16%
Sleep Disturbance
16%
Hepatic Glucose Metabolism
16%
Non-diabetic
16%
Liver Tissue
16%
Serum Insulin
16%
Glucagon
16%
Resting Period
16%
Body Weight Gain
16%
Rapid Eye Movement Sleep
16%
Drug Target
16%
Hepatic Fat
16%
Coactivator
16%
Regulatory System
16%
Pharmacological Intervention
16%
Biochemistry, Genetics and Molecular Biology
Glucose Metabolism
100%
Orexin
100%
Db/Db Mouse
100%
Suvorexant
100%
Sleep Time
33%
Metabolic Pathway
16%
Triglyceride
16%
Peroxisome Proliferator-Activated Receptor
16%
Insulin Sensitivity
16%
Lipid Metabolism
16%
Metabolic Disorder
16%
Tumor Necrosis Factor
16%
Wakefulness
16%
Phosphoenolpyruvate Carboxykinase
16%
Impaired Glucose Tolerance
16%
Body Weight Gain
16%
Eye Movement
16%
Glucagon Blood Level
16%
Drug Targeting
16%
Insulin Blood Level
16%
Messenger RNA
16%
Torpor
16%
Immunology and Microbiology
Glucose Metabolism
100%
Db/Db Mouse
100%
Sleep Time
50%
Adipose Tissue
25%
Tumor Necrosis Factor
25%
Insulin Blood Level
25%
Lipid Metabolism
25%
Insulin Sensitivity
25%
Peroxisome
25%
Liver Tissue
25%
Eye Movement
25%
Glucagon Blood Level
25%
Body Weight Gain
25%
Drug Targeting
25%
Torpor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Orexin
100%
Db/Db Mouse
100%
Suvorexant
100%
Non Insulin Dependent Diabetes Mellitus
33%
Triacylglycerol
16%
Inflammation
16%
Tumor Necrosis Factor
16%
Peroxisome Proliferator Activated Receptor
16%
Phosphoenolpyruvate Carboxykinase (GTP)
16%
Impaired Glucose Tolerance
16%
Drug Delivery System
16%
Sleep Disorder
16%
Metabolic Disorder
16%
Glucagon
16%
Messenger RNA
16%
Neuroscience
Orexin
100%
Metabolic Pathway
100%
Suvorexant
100%
Sleep Time
33%
Wakefulness
16%
Sleep Disorder
16%
Adipose Tissue
16%
Eye Movement
16%
Phosphoenolpyruvate Carboxykinase
16%
Glucagon
16%
Metabolic Disorder
16%
Triacylglycerol
16%
Peroxisome Proliferator-Activated Receptor
16%
Messenger RNA
16%
Agricultural and Biological Sciences
Mouse
100%
Glucose Tolerance
16%
Impaired Glucose Tolerance
16%
Adipose Tissue
16%
Torpor
16%
Peroxisome Proliferator-Activated Receptor
16%
Food Intake
16%
Tumor Necrosis Factor
16%
Triglyceride
16%
Phosphoenolpyruvate Carboxykinase (GTP)
16%
Weight Gain
16%
Lipid Metabolism
16%
Messenger RNA
16%
Glucagon
16%
Body Weight
16%
Remediation
16%